Norouzinia Mohsen, Zamanian Azodi Mona, Najafgholizadeh Seyfi Diba, Kardan Ali, Naseh Ali, Akbari Zahra
Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Gastroenterol Hepatol Bed Bench. 2019;12(Suppl1):S44-S50.
The main goal of this investigation was to provide an overview on effect on gastric tissue via bioinformatics analysis of microarray-identified miRNAs and its target genes.
MicroRNAs which control about 30 to 60% of gene expression in human body play a critical role in different cell growth stages. Expression modification of non-coding (NC) RNAs in H.pylori infections requires further investigations to provide better understanding of their roles in the body.
GSE54397, the microRNA microarray dataset, was analyzed by GEO2R, the online GEO database for detection of differentially expressed microRNAs and lastly the potential target genes as well as their associated pathways.
A total of 244 miRNAs were detected as differentially expressed (p<0.05 and FC>2) in non-cancerous tissue of gastric with H.pylori infection in comparison with tissues without H.pylori infection. The findings indicated that hub microRNAs and target genes of up-regulated network are KIF9, DCTN3, and CA5BP1 along with hsa-miR-519d, hsa-miR-573, hsa-miR-646, hsa-miR-92a-1, hsa-miR-186, and hsa-miR-892a, respectively. For the down-regulated network, genes of RABGAP1, HSPB11 and microRNAs of hsa-miR-620, hsa-miR-19b-2, hsa-miR-555, and hsa-let-7f-2 were hubs. Most of the up-regulated microRNAs are involved in gastric cancer development while there is no evidence for the down-regulated ones. Yet, all of the hub down-regulated miRNAs are reported to have associations with different kinds of cancer.
The introduced hub miRNAs and genes may serve as feasible markers in the mechanisms of infection for different kinds of gastric diseases, in particular gastric cancer. However, their role requires further investigations.
本研究的主要目标是通过对微阵列鉴定的miRNA及其靶基因进行生物信息学分析,概述其对胃组织的影响。
控制人体约30%至60%基因表达的微小RNA在不同细胞生长阶段起着关键作用。幽门螺杆菌感染中非编码(NC)RNA的表达修饰需要进一步研究,以更好地了解它们在体内的作用。
通过在线GEO数据库GEO2R分析微RNA微阵列数据集GSE54397,以检测差异表达的微RNA,最后分析潜在的靶基因及其相关途径。
与未感染幽门螺杆菌的组织相比,在感染幽门螺杆菌的胃非癌组织中,共检测到244种差异表达的miRNA(p<0.05且FC>2)。研究结果表明,上调网络的核心miRNA和靶基因分别是KIF9、DCTN3和CA5BP1,以及hsa-miR-519d、hsa-miR-573、hsa-miR-646、hsa-miR-92a-1、hsa-miR-186和hsa-miR-892a。对于下调网络,核心基因是RABGAP1、HSPB11,核心miRNA是hsa-miR-620、hsa-miR-19b-2、hsa-miR-555和hsa-let-7f-2。大多数上调的miRNA参与胃癌的发生发展,而下调的miRNA则无此证据。然而,所有下调的核心miRNA均被报道与不同类型的癌症有关。
所引入的核心miRNA和基因可能是不同类型胃病尤其是胃癌感染机制中的可行标志物。然而,它们的作用还需要进一步研究。